Full text

Turn on search term navigation

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

COVID-19 is a complex multisystemic disease that can result in long-term complications and, in severe cases, death. This study investigated the effect of COVID-19 on carotid–femoral pulse wave velocity (cfPWV) as a measurement to evaluate its impact on arterial stiffness and might help predict COVID-19-related cardiovascular (CV) complications. PubMed, Web of Science, Embase, and the Cochrane Library were searched for relevant studies, and meta-analysis was performed. The study protocol was registered in PROSPERO (nr. CRD42023434326). The Newcastle–Ottawa Quality Scale was used to evaluate the quality of the included studies. Nine studies reported cfPWV among COVID-19 patients and control groups. The pooled analysis showed that cfPWV in COVID-19 patients was 9.5 ± 3.7, compared to 8.2 ± 2.2 in control groups (MD = 1.32; 95% CI: 0.38–2.26; p = 0.006). A strong association between COVID-19 infection and increased cfPWV suggests a potential link between the virus and increased arterial stiffness. A marked increase in arterial stiffness, a known indicator of CV risk, clearly illustrates the cardiovascular implications of COVID-19 infection. However, further research is required to provide a clearer understanding of the connection between COVID-19 infection, arterial compliance, and subsequent CV events.

Details

Title
The Impact of COVID-19 on Carotid–Femoral Pulse Wave Velocity: A Systematic Review and Meta-Analysis
Author
Jannasz, Iwona 1   VIAFID ORCID Logo  ; Pruc, Michal 2   VIAFID ORCID Logo  ; Mansur Rahnama-Hezavah 3 ; Targowski, Tomasz 1 ; Olszewski, Robert 4   VIAFID ORCID Logo  ; Feduniw, Stepan 5   VIAFID ORCID Logo  ; Petryka, Karolina 6 ; Szarpak, Lukasz 7   VIAFID ORCID Logo 

 Department of Geriatrics, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland 
 Research Unit, Polish Society of Disaster Medicine, 05-806 Warsaw, Poland; Department of Public Health, International Academy of Ecology and Medicine, 02-091 Kyiv, Ukraine 
 Chair and Department of Oral Surgery, Medical University of Lublin, 20-093 Lublin, Poland 
 Department of Gerontology, Public Health and Education, National Institute of Geriatrics Rheumatology and Rehabilitation, 02-637 Warsaw, Poland 
 Department of Gynecology, University Hospital Zurich, 8091 Zurich, Switzerland; Department of Obstetrics, University Hospital Zurich, 8091 Zurich, Switzerland 
 Research Unit, Internal Medicine Clinic, 03-003 Warsaw, Poland; [email protected] 
 Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX 77030, USA; Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy in Warsaw, 00-136 Warsaw, Poland; Research Unit, Maria Sklodowska-Curie Bialystok Oncology Center, 15-027 Bialystok, Poland 
First page
5747
Publication year
2023
Publication date
2023
Publisher
MDPI AG
e-ISSN
20770383
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2862578636
Copyright
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.